Pandemic disrupts IP filings, licensing

By
-
TECH IN USE: John Jarrell, left, president of Materials Science Associates, and Dr. Christopher Born, director of orthopedic trauma at Rhode Island Hospital, work to apply a patented anti-microbial technology in a surgical procedure to reduce infection of medical implants. ­Jarrell has increased his company’s investment in patent filings and other intellectual property activity to respond to ­COVID-19. / COURTESY MATERIALS SCIENCE ASSOCIATES LLC
TECH IN USE: John Jarrell, left, president of Materials Science Associates, and Dr. Christopher Born, director of orthopedic trauma at Rhode Island Hospital, work to apply a patented anti-microbial technology in a surgical procedure to reduce infection of medical implants. ­Jarrell has increased his company’s investment in patent filings and other intellectual property activity to respond to ­COVID-19. / COURTESY MATERIALS SCIENCE ASSOCIATES LLC
Innovation is at the heart of John Jarrell’s entrepreneurial success. Over the last two decades, the Brown University graduate with degrees in engineering and medical science has helped start more than half a dozen Rhode Island companies, from medical device and drug delivery consulting firm Materials Science Associates LLC, to a chemical coating product company,…


You must be a paid subscriber to read this content.

To keep reading and receive unlimited access subscribe today for only $1.


Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

RELATED ARTICLESMORE FROM AUTHOR

No posts to display